Title:
Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)
Agreement Value:
$157,825.00
Agreement Date:
Mar 1, 2025 - Feb 28, 2026
Description:
The CIHR Institute of Genetics (CIHR-IG) will provide funding for applications that are determined to be relevant to its mandate:
• CIHR-IG supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries.
Organization:
Canadian Institutes of Health Research
Expected Results:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.
Location:
Ottawa, Ontario, CA K1Y 4E9
Reference Number:
236-2024-2025-Q4-00409
Report Type:
Grants and Contributions
Recipient Type:
Individual or sole proprietorship
Additional Information:
Amendment 1: Agreement Value in CAD.
Amendment Date
Jun 30, 2025
Recipient's Legal Name:
Mattar, Pierre Adel
Research Organization:
Ottawa Hospital Research Institute|Institut de recherche de l’Hôpital d’Ottawa
Program:
Research in Priority Areas
Program Purpose:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.